OMB Proposes Rule Mandating Federal Grants Align With Presidential Priorities

The common misconception about federal grantmaking is that it is merely an accounting exercise—a bureaucratic plumbing system moving money from Washington to states, universities, and nonprofits. In reality, this apparatus is the engine of American scientific innovation, local infrastructure, and public health.

For decades, the distribution of these discretionary funds has relied heavily on independent peer review, insulating scientific and community investments from the immediate political demands of the executive branch. That structural firewall is now the target of a sweeping regulatory overhaul.

On May 29, 2026, the Office of Management and Budget (OMB) published a proposed rewrite of 2 CFR Part 200, the uniform guidance that governs all federal financial assistance. The rule mandates that federal grants must demonstrably advance the policy priorities of the sitting president, fundamentally altering the criteria for who receives federal money.[1]

The mechanism of the proposed rule is straightforward but profound. It requires that senior political appointees conduct a pre-issuance review of discretionary awards, effectively downgrading the traditional peer-review process to a purely advisory role.

Under the new framework, high marks from scientific or subject-matter experts would no longer be sufficient to secure funding. Instead, political appointees would evaluate whether a proposed project aligns with the administration's broader policy principles before any money is disbursed.

The rule also vastly expands the authority of federal agencies to suspend or terminate existing grants. Currently, grants are typically only pulled for non-performance or financial mismanagement. The OMB proposal allows agencies to cancel awards at any time if they determine the project no longer effectuates agency priorities or the national interest.

This termination-for-convenience clause means that a multi-year research project or a community health initiative could lose its funding overnight if the executive branch's political priorities shift, placing grantees under a permanent threat of cancellation.

Beyond the structural changes to approval and termination, the rule explicitly targets specific types of research and programming. It prohibits the use of federal funds to promote, encourage, or facilitate diversity, equity, and inclusion (DEI) practices, as well as what the administration terms "gender ideology."

The proposal also places strict new constraints on international collaboration, particularly with entities in covered foreign countries, and requires agencies to prioritize domestic-only work. Furthermore, it introduces a "Gold Standard Science" benchmark and an anti-prestige provision, directing agencies to prioritize rigorous scholarship over an institution's historical reputation.

The stated intent of the OMB, led by Director Russ Vought, is to improve transparency, accountability, and oversight. The administration argues that executive branch agencies have a constitutional duty to ensure that taxpayer dollars are not spent on initiatives that conflict with the president's agenda.[1]

However, the proposal has triggered an unprecedented backlash from the institutions that actually perform federally funded work. By the close of the public comment period on July 13, 2026, nearly 100,000 comments had been submitted, the vast majority in fierce opposition.

The American Council on Education, joined by over 60 other higher education associations, warned that shifting from merit-based peer review to political decision-making would severely weaken the foundation of the federal-academic partnership, threatening America's leadership in medical and scientific research.

State and local governments have echoed these alarms. A coalition of lawmakers from all 50 states argued that the rule transforms a stable funding system into a punitive and retaliatory environment, jeopardizing essential services like disaster relief, housing, and public health.

Civil rights organizations, including the ACLU, have pointed out that the broad, vague criteria for denying or terminating funds could be weaponized to suppress private speech and undermine anti-discrimination protections.[2]

The structural critique of the OMB rule centers on the separation of powers. Critics argue that by allowing political appointees to withhold or cancel funds based on ideological alignment, the executive branch is effectively usurping Congress's constitutional power of the purse.

If Congress appropriates money for a specific competitive grant program, but the OMB refuses to disburse it because the applicants do not align with the president's priorities, the executive branch is overriding legislative intent through administrative procedure.

The OMB intends to finalize the rule so that it takes effect on October 1, 2026, applying to Fiscal Year 2027 funding. Anticipating inevitable legal challenges, the administration included a severability clause, ensuring that if courts strike down specific provisions, the broader structural shift toward political control remains intact.

As the October deadline approaches, the federal grantmaking ecosystem remains in a state of deep uncertainty. The rule guarantees that regardless of which party holds the White House, the distribution of federal research and community funds will become an explicitly partisan exercise.